Table 3.
Values | Hazard Ratio | |||
---|---|---|---|---|
Univariable Analysis | p-Value | Multivariable Analysis | p-Value | |
Age (≥70 years) | 2.22 (1.25–3.94) | 0.01 | 2.07 (1.15–3.73) | 0.02 |
Male sex | 0.34 (0.18–0.63) | <0.01 | 0.38 (0.19–0.70) | <0.01 |
Hypertension | 0.99 (0.56–1.74) | 0.97 | ||
Diabetes mellitus | 0.98 (0.55–1.76) | 0.95 | ||
Chronic kidney disease | 1.00 (0.43–2.36) | 0.99 | ||
Stroke | 0.37 (0.05–2.68) | 0.32 | ||
Previous PCI | 0.94 (0.42–2.09) | 0.88 | ||
Aspirin | 0.59 (0.29–1.23) | 0.16 | ||
Clopidogrel | 1.02 (0.32–3.33) | 0.96 | ||
Statins | 0.95 (0.43–2.12) | 0.90 | ||
ACEi/ARB | 0.61 (0.26–1.44) | 0.26 | ||
CCB | 0.37 (0.11–1.19) | 0.09 | ||
Post-revascularization EF ( ≥ 30%) | 0.79 (0.40–1.60) | 0.52 | ||
CPR start (≤9 min) | 0.89 (0.47–1.73) | 0.73 | ||
CPR duration | 1.01 (0.99–1.02) | 0.14 | ||
ECMO duration (≥6 days) | 0.43 (0.24–0.77) | 0.005 | 0.38 (0.21–0.72) | 0.01 |
PCI to LM or LAD | 1.15 (0.63–2.09) | 0.66 | ||
Bailout ECMO | 0.82 (0.46–1.45) | 0.50 | ||
In-hospital shock | 1.77 (0.99–3.16) | 0.053 | 2.02 (1.07–3.81) | 0.03 |
ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; CCB, calcium channel blocker; CPR, cardiopulmonary resuscitation; EF, ejection fraction; ECMO, extracorporeal membrane oxygenation; LAD, left anterior descending artery; LM, left main; min, minutes; PCI, percutaneous coronary intervention; RCA, right coronary artery.